Oxford research advances scalable approaches to cell and tissue engineering

Researchers at our Institute of Biomedical Engineering, led by Prof Zhanfeng Cui, are developing advanced engineering approaches to support the growth, manipulation and manufacture of living cells and tissues. The work centres on designing controlled bioprocessing systems that enable cells particularly stem cells—to be expanded reliably and at scale.

A key focus of Prof Cui’s research is creating reproducible environments for cell culture, where factors such as nutrient delivery, mechanical conditions and microstructure can be precisely managed. These engineered systems are essential for moving cell-based technologies beyond the laboratory, supporting applications in regenerative medicine, diagnostics and therapeutic development.

By improving how biological materials are produced and handled, the research addresses one of the major challenges in the field: scaling up complex biological processes without compromising quality or consistency. This has direct relevance for areas such as tissue engineering and cell therapies, where manufacturing constraints often limit clinical translation.

The work also draws on interdisciplinary collaboration, combining expertise in engineering, biology and medicine to refine these technologies and explore their practical applications. Such approaches are helping to bridge the gap between fundamental research and real-world healthcare solutions.

His expertise in bioprocessing and cell engineering was recently featured in a EurekAlert article, underlining the relevance of this work to ongoing developments in biomedical engineering.

Read the full article: https://www.eurekalert.org/news-releases/11225050